Anthrax may be the next tool in the fight against bladder cancer

November 13, 2019

Anthrax may soon help more people win the fight against bladder cancer, which the U.S. Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000, and is one of the most expensive cancers to treat.

Pet dogs suffering bladder cancer, for which all other approaches failed, were treated with a Purdue University experimental approach. A: Bladder cystoscopic biopsy being performed in patient dog to investigate tumor characteristics. B: Ultrasound image obtained to record tumor mass dimensions. Sagittal view of the bladder. Arrows point to mass in the neck of the bladder. C: Presence of Epidermal Growth Factor (EGF) Receptor on bladder cancer cells was revealed by binding and uptake of fluorescently labeled EGF (red). Nucleus (blue) and actin cytoskeleton (green) are also shown. (Image Provided)

The current treatments for bladder cancer are invasive for patients – who often must sit for hours at a time with a bladder full of an agent designed to kill cancer cells and tumors. Bladder cancer also is one of the most recurring for people diagnosed with the disease.

Now, researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors. The research is published in the Oct. 4 edition of the International Journal of Cancer.

R. Claudio Aguilar and his group worked with the Purdue teams led by Timothy Ratliff, a distinguished professor of comparative pathobiology and the Robert Wallace Miller Director of Purdue University Center for Cancer Research; and Deborah Knapp, the Dolores L. McCall Professor of Comparative Oncology and director of the Purdue Comparative Oncology Program, to test their solution in dogs with bladder cancer who had run out of other treatment options. They found this new agent decreased the tumor size without causing any other side effects in the animals.

Read the full story at Anthrax may be the next tool in the fight against bladder cancer

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

Behind the scenes, Alicia Williams has been making PVM a kinder, stronger place.

Purdue Veterinary Medicine Computational Biologist Uses Big Data, AI and Math to Find Patterns in Cancer

With recent advances, cancer research now generates vast amounts of information. The data could help researchers detect patterns in cancer cells and stop their growth, but the sheer volume is just too much for the human mind to digest. Enter Nadia Lanman, research associate professor in the Department of Comparative Pathobiology, whose expertise in computational biology helps researchers at Purdue University distill solutions from the sea of numbers.

Purdue to Host Fourth Annual Antimicrobial Conference in February

With leadership by the Purdue University College of Veterinary Medicine, the Fourth Annual Conference on Antimicrobial Resistance (AMR) will be held at Purdue University West Lafayette February 25–26, 2026. With multidrug-resistant infections on the rise globally, this event brings together experts and practitioners across the spectrum of human, animal, and environmental health to address one of today’s most urgent public health challenges.

PVM Well-represented by Humans and Animals During Annual Homecoming Celebrations

Every fall, Boilermakers from near and far return to the campus in West Lafayette for the annual ritual known as Homecoming. And Purdue’s Homecoming events also attract plenty of non-alumni who are Purdue fans, patrons, prospective students, or clients of the Purdue University Veterinary Hospital. During this year’s Homecoming weekend October 24-25, Purdue Veterinary Medicine engaged with attendees in multiple ways, with the help of some furry companions.

Purdue University and Akston Biosciences Bring “First Dose of Hope” in New Cancer Immunotherapy Trial for Dogs with Urinary Bladder Cancer

The Purdue University College of Veterinary Medicine, in partnership with Akston Biosciences Corporation, has initiated the enrollment of dogs with urinary bladder cancer in a clinical trial of a pioneering immunotherapy. The strategic partnership between Purdue and Akston was announced in August after the underlying technology was developed at the College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR).

“Paws Up” – brought to you by the PVM Wellness Committee

Today we share appreciation for Beth Laffoon, MS, RVT, and Holly McCalip, BS, RVT, who are both instructional technologists in the Veterinary Nursing Program.

MMAS Symposium Brings Participants Face to Face with Specialists and Species from Parrots to Pocket Pets

Thanks to Purdue Veterinary Medicine’s Exotic Animal Club and dedicated faculty, staff and students, nearly 100 in-person and on-line participants got a chance recently to gain valuable knowledge and insight about the Medicine of Mammalian and Avian Species. The two-day educational event known as the MMAS Symposium is a biennial conference, and the 2024 edition held in Lynn Hall November 9 and 10 featured an impressive program that included 22 lectures and several hands-on labs, organized into two tracks focusing on avian and mammalian species.

Veterinary Boilermakers Take Part in Purdue One Health Alumni Reunion

Purdue University College of Veterinary Medicine faculty, staff and students turned out for Purdue University’s first One Health Alumni Reunion, which was held on the West Lafayette campus November 14-16. They joined more than 150 Boilermakers from a variety of medical professions who came together to network and participate in timely discussions with Purdue President Mung Chiang, First Lady Kei Hui and fellow alumni.